Literature DB >> 7071458

Polymicrobial osteomyelitis: report of three cases and review of the literature.

M E Pichichero, H A Friesen.   

Abstract

Five percent of patients with acute osteomyelitis and 30%-60% of patients with chronic osteomyelitis have polymicrobial infections. Three illustrative cases and a review of the literature involving 104 patients are presented in this report. There were 2.4 isolates per child among the 31 pediatric cases ad 3.9 isolates per adult among the 71 adult cases reviewed. Staphylococcus aureus was the single most common isolate involved in polymicrobial disease in both adults and children. In adults, one-third of the aerobic isolates were gram-negative bacterial species; some enterococci were also involved. Of the isolates from adults, 46% were anaerobic. The number of isolates per case was similar for the acute (3.2) and chronic (3.1) forms of infection. Polymicrobial osteomyelitis resulted most frequently from spread of infection from a contiguous focus (59% of cases) or occurred in the patient with peripheral vascular insufficiency or neuropathy (17% of cases); however, the hematogenous route can produce polymicrobial disease (13% of cases). Bones mot often involved are those of the skull, face, and feet. Standard antibiotic therapy for monomicrobial osteomyelitis with semisynthetic penicillins or cephalosporins may lead to failures of treatment in polymicrobial disease.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7071458     DOI: 10.1093/clinids/4.1.86

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  5 in total

Review 1.  Anaerobic osteomyelitis in children.

Authors:  Claudia M Espinosa; Matthew M Davis; Janet R Gilsdorf
Journal:  Pediatr Infect Dis J       Date:  2011-05       Impact factor: 2.129

Review 2.  Staphylococcal Osteomyelitis: Disease Progression, Treatment Challenges, and Future Directions.

Authors:  Nicola Kavanagh; Emily J Ryan; Amro Widaa; Gillian Sexton; Jerome Fennell; Sadhbh O'Rourke; Kevin C Cahill; Cathal J Kearney; Fergal J O'Brien; Steven W Kerrigan
Journal:  Clin Microbiol Rev       Date:  2018-02-14       Impact factor: 26.132

3.  Sulbactam/ampicillin versus cefotaxime as initial therapy in serious soft tissue, joint and bone infections.

Authors:  L Löffler; A Bauernfeind; W Keyl
Journal:  Drugs       Date:  1988       Impact factor: 9.546

4.  Current concepts in the management of infections in bones and joints.

Authors:  A S Dickie
Journal:  Drugs       Date:  1986-11       Impact factor: 9.546

5.  Ceftazidime as single-agent therapy for gram-negative aerobic bacillary osteomyelitis.

Authors:  M C Bach; D M Cocchetto
Journal:  Antimicrob Agents Chemother       Date:  1987-10       Impact factor: 5.191

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.